lidocaine + propofol + fentanyl + cisatracurium

This is a combination of four pharmaceutical agents commonly used together for the induction and maintenance of general anesthesia, particularly in surgical and critical care settings. Each component serves a distinct role: - **Lidocaine** is a local anesthetic that blocks sodium channels, reducing pain on injection and providing local anesthesia. - **Propofol** is an intravenous anesthetic agent that acts as a positive allosteric modulator of the GABA-A receptor, inducing rapid loss of consciousness for anesthesia induction and maintenance[2]. - **Fentanyl** is a potent synthetic opioid analgesic that acts primarily as an agonist at the mu-opioid receptor, providing strong analgesia during procedures[8]. - **Cisatracurium** is a non-depolarizing neuromuscular blocking agent (muscle relaxant) that antagonizes nicotinic acetylcholine receptors at the neuromuscular junction to facilitate tracheal intubation and muscle relaxation during surgery or mechanical ventilation[5][6]. This combination provides comprehensive anesthesia by ensuring unconsciousness (propofol), analgesia (fentanyl), muscle relaxation (cisatracurium), and reduction in injection pain (lidocaine)[1][3]. It does not have a unique brand name or fixed-dose formulation; rather, it refers to concurrent administration of these agents.